T.Rowe Price Associates Form 8.3 - [PFIZER INC] (5027G)
20 Novembro 2015 - 1:11PM
UK Regulatory
TIDMPFZ
RNS Number : 5027G
T.Rowe Price Associates
20 November 2015
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT,
1997,
TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing T. ROWE PRICE ASSOCIATES, INC.
(Note 1)
-------------------------------------- -------------------------------
Company dealt in PFIZER INC
-------------------------------------- -------------------------------
Class of relevant security ISIN: US7170811035
to which the dealings
being disclosed relate
(Note 2)
-------------------------------------- -------------------------------
Date of dealing 19 November 2015
-------------------------------------- -------------------------------
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the
class of relevant security dealt in (Note 3)
Long Short
--------------------------------- ------------------ -----------
Number (%) Number (%)
--------------------------------- ------------------ -----------
(1) Relevant securities 109,258,491 1.77%
--------------------------------- ------------------ -----------
(2) Derivatives (other
than options)
--------------------------------- ------------------ -----------
(3) Options and agreements
to purchase/sell
--------------------------------- ------------------ -----------
Total 109,258,491 1.77%
--------------------------------- ------------------ -----------
(b) Interests and short positions in relevant securities of the
company, other than the class dealt in (Note 3)
Class of relevant security: Long Short
-------------------------------- ----------- -----------
Number (%) Number (%)
-------------------------------- ----------- -----------
(1) Relevant securities
-------------------------------- ----------- -----------
(2) Derivatives (other
than options)
-------------------------------- ----------- -----------
(3) Options and agreements
to purchase/sell
-------------------------------- ----------- -----------
Total
-------------------------------- ----------- -----------
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of securities Price per unit (Note
5)
-------------- --------------------- ---------------------
Purchases 3,900 32.146 USD
247,300 32.217 USD
68,400 32.290 USD
Sales 11,500 32.147 USD
2,600 32.290 USD
4,000 32.800 USD
-------------- --------------------- ---------------------
(b) Derivatives transactions (other than options)
Product name, Long/short Number of securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
-------------- ----------- --------------------- ---------------
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, Number of Exercise Type, Expiry Option
e.g. call selling, securities price e.g. American, date money
option purchasing, to which European paid/received
varying the option etc. per unit
etc. relates (Note (Note 5)
7)
-------------- ------------- --------------- --------- ---------------- ------- ---------------
(ii) Exercising
Product name, e.g. Number of securities Exercise price per
call option unit (Note 5)
------------------- --------------------- -------------------
(d) Other dealings (including new securities) (Note 4)
Nature of transaction Details Price per unit (if
(Note 8) applicable) (Note
5)
---------------------- -------- -------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating
to the voting rights of any relevant securities under
any option referred to on this form or relating to the
voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred
to on this form is referenced. If none, this should
be stated.
-------------------------------------------------------------
None
-------------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 20 November 2015
--------------------------------------------- -----------------
Contact name Gary Greb
--------------------------------------------- -----------------
Telephone number 001 410 345 2527
--------------------------------------------- -----------------
If a connected EFM, name of offeree/offeror
with which connected
--------------------------------------------- -----------------
If a connected EFM, state nature
of connection (Note 10)
--------------------------------------------- -----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
ISEURRVRVWAAUAA
(END) Dow Jones Newswires
November 20, 2015 10:11 ET (15:11 GMT)
Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025
